✦ LIBER ✦

Case studies of fulvestrant (‘Faslodex’) in postmenopausal women with advanced breast cancer

✍ Scribed by Paul Abram; Nicolai Maass; Daniel Rea; Sergio D. Simon; Guenther G. Steger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Equivalent single-dose pharmacokinetics

✍ JohnF.R. Robertson; M.P. Harrison 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 167 KB

Fulvestrant (Faslodex™) in advanced brea

✍ Patrick Neven; Robert Paridaens; Gino Pelgrims; Marc Martens; Alain Bols; Jean C 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 222 KB

Fulvestrant: an effective second-line tr

✍ D Dodwell; I Vergote 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Fulvestrant (‘Faslodex’) in pre-treated

✍ G.G. Steger; R. Bartsch; C. Wenzel; U. Pluschnig; D. Hussian; U. Sevelda; G.J. L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Fulvestrant (‘Faslodex’) in heavily pret

✍ Brigitte Mlineritsch; Oskar Psenak; Peter Mayer; Martin Moik; Konrad Namberger; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 300 KB

Fulvestrant versus anastrozole as second

✍ I Vergote 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 68 KB